Search filters

List of works by Alice Laroni

A case of thyroiditis during natalizumab therapy for multiple sclerosis

scientific article published on 01 May 2011

A multicentRE observational analysiS of PErsistenCe to Treatment in the new multiple sclerosis era: the RESPECT study.

scientific article published on 16 March 2018

Activation of the aryl hydrocarbon receptor induces human type 1 regulatory T cell-like and Foxp3(+) regulatory T cells

scientific article

Approved drugs for multiple sclerosis: the challenge of choice

scientific article published on 11 February 2017

Association of melanoma and natalizumab therapy in the Italian MS population: a second case report

article

Autologous hematopoietic stem cell transplantation in multiple sclerosis: A meta-analysis.

scientific article published on 28 April 2017

CD56bright Natural Killer Cells: A Possible Biomarker of Different Treatments in Multiple Sclerosis

scientific article published on 13 May 2020

COVID-19 in patients with multiple sclerosis undergoing disease-modifying treatments

scientific article published on 18 November 2020

Can we kill an extra bird with the same stone?

scientific article published on 24 June 2011

Cardiovascular autonomic individual profile of relapsing-remitting multiple sclerosis patients and risk of extending cardiac monitoring after first dose fingolimod

scientific article published on 08 August 2019

Clinical baseline factors predict response to natalizumab: their usefulness in patient selection

scientific article

Clinical, laboratory features, and prognostic factors in adult acute transverse myelitis: an Italian multicenter study

scientific article published on 22 March 2019

Composite MRI measures and short-term disability in patients with clinically isolated syndrome suggestive of MS

scientific article published on 10 April 2017

Conversion from clinically isolated syndrome to multiple sclerosis: A large multicentre study.

scientific article

Determinants of therapy switch in multiple sclerosis treatment-naïve patients: A real-life study

scientific article published on 25 July 2018

Dysregulation of regulatory CD56(bright) NK cells/T cells interactions in multiple sclerosis.

scientific article

Enhancing natural killer cells is beneficial in multiple sclerosis - Yes

scientific article published on 13 November 2018

Extending the Interval of Natalizumab Dosing: Is Efficacy Preserved?

scientific article published on 01 January 2020

Factors interfering with parenthood decision-making in an Italian sample of people with multiple sclerosis: an exploratory online survey

scientific article published on 16 January 2019

IL-27 Imparts Immunoregulatory Function to Human NK Cell Subsets ⬇️

scientific article published on October 19, 2011

Impact of treatment on cellular immunophenotype in MS: A cross-sectional study

scientific article published on 05 March 2020

In vitro VLA-4 blockade results in an impaired NK cell-mediated immune surveillance against melanoma.

scientific article published on 2 December 2016

Long-term disability progression in primary progressive multiple sclerosis: a 15-year study

scientific article published on 27 September 2017

Magnetic Resonance Imaging Finding of Periodontal and Inferior Alveolar Nerve Inflammation in a Subject With Trigeminal Neuralgia

scientific article published on 31 October 2020

Mesenchymal stem cells as treatment for MS - progress to date.

scientific article

Mesenchymal stem cells for the treatment of neurological diseases: Immunoregulation beyond neuroprotection

scientific article published on 18 August 2015

Neuroprotective features of mesenchymal stem cells.

scientific article published on 25 February 2011

No evidence of disease activity (NEDA-3) and disability improvement after alemtuzumab treatment for multiple sclerosis: a 36-month real-world study

scientific article published on 26 September 2018

Outcomes after fingolimod to alemtuzumab treatment shift in relapsing-remitting MS patients: a multicentre cohort study

scientific article published on 17 June 2019

Overexpression of sphingosine-1-phosphate receptors on reactive astrocytes drives neuropathology of multiple sclerosis rebound after fingolimod discontinuation

scientific article published on 30 April 2018

Pregnancy decision-making in women with multiple sclerosis treated with natalizumab: I: Fetal risks

scientific article published on 7 February 2018

Pregnancy decision-making in women with multiple sclerosis treated with natalizumab: II: Maternal risks

scientific article published on 7 February 2018

Regulatory Functions of Natural Killer Cells in Multiple Sclerosis.

scientific article published on 19 December 2016

Safety and tolerability of fingolimod in patients with relapsing-remitting multiple sclerosis: results of an open-label clinical trial in Italy

scientific article

Serum sickness (Like Reaction) in a patient treated with alemtuzumab for multiple sclerosis: A case report

scientific article published on 11 September 2018

Teriflunomide treatment reduces B cells in patients with MS.

scientific article published on 23 October 2017

Three years of experience: the Italian registry and safety data update.

scientific article

Urinary JCV-DNA Testing during Natalizumab Treatment May Increase Accuracy of PML Risk Stratification

scientific article published on 16 May 2012

Paulina is supported by:

About Paulina

Help